Spectrum of antibiotic resistance in UTI caused by Escherichia coli among HIV-infected patients in Uganda: a cross-sectional study

Abstract Background Antimicrobial drug resistance is one of the top ten threats to global health according to the World Health Organization. Urinary tract infections (UTIs) are among the most common bacterial infections and main reason for antibiotic prescription. The incidence of UTIs appears to be...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: George Abongomera, Maurice Koller, Joseph Musaazi, Mohammed Lamorde, Marisa Kaelin, Hannington B. Tasimwa, Nadia Eberhard, Jan Hongler, Sabine Haller, Andrew Kambugu, Barbara Castelnuovo, Jan Fehr
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
HIV
Acceso en línea:https://doaj.org/article/f6a2451d3b464a22b21d8e2b08fec13f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f6a2451d3b464a22b21d8e2b08fec13f
record_format dspace
spelling oai:doaj.org-article:f6a2451d3b464a22b21d8e2b08fec13f2021-11-28T12:41:50ZSpectrum of antibiotic resistance in UTI caused by Escherichia coli among HIV-infected patients in Uganda: a cross-sectional study10.1186/s12879-021-06865-31471-2334https://doaj.org/article/f6a2451d3b464a22b21d8e2b08fec13f2021-11-01T00:00:00Zhttps://doi.org/10.1186/s12879-021-06865-3https://doaj.org/toc/1471-2334Abstract Background Antimicrobial drug resistance is one of the top ten threats to global health according to the World Health Organization. Urinary tract infections (UTIs) are among the most common bacterial infections and main reason for antibiotic prescription. The incidence of UTIs appears to be high among people living with HIV. We sought to determine the most common UTI pathogens among HIV infected patients and evaluate their susceptibility towards antibiotics. Methods We performed a cross-sectional study among HIV-infected patients aged ≥ 18 years presenting at an HIV care specialized clinic with symptoms suggestive of a urethritis. Urine cultures were subjected to antibiotic susceptibility testing according to Clinical Laboratory Standards Institute. The data was analyzed using STATA, we performed Pearson’s Chi-square and Fisher’s exact tests to compare differences between proportions. Results Out of the 200 patients, 123 (62%) were female. The median age was 41.9 years (IQR 34.7–49.3). Only 32 (16%) urine cultures showed bacterial growth. Escherichia coli was the most commonly isolated uropathogen (72%), followed by Klebsiella pneumoniae (9%). E. coli was completely resistant to cotrimoxazole and ampicillin; resistance to ciprofloxacin and ceftriaxone was 44% and 35% respectively; 9% to gentamicin; no resistance detected to nitrofurantoin and imipenem. Conclusions Our findings are congruent with the Uganda national clinical guidelines which recommends nitrofurantoin as the first line antibiotic for uncomplicated UTI. Significant ciprofloxacin and ceftriaxone resistance was detected. In the era of emerging antibiotic resistance, understanding the local susceptibilities among sub-populations such as HIV infected patients is crucial. Further investigation is needed to address reasons for the low bacterial growth rate observed in the urine cultures.George AbongomeraMaurice KollerJoseph MusaaziMohammed LamordeMarisa KaelinHannington B. TasimwaNadia EberhardJan HonglerSabine HallerAndrew KambuguBarbara CastelnuovoJan FehrBMCarticleUrinary tract infectionsAntimicrobial resistanceHIVUgandaSub-Saharan AfricaInfectious and parasitic diseasesRC109-216ENBMC Infectious Diseases, Vol 21, Iss 1, Pp 1-7 (2021)
institution DOAJ
collection DOAJ
language EN
topic Urinary tract infections
Antimicrobial resistance
HIV
Uganda
Sub-Saharan Africa
Infectious and parasitic diseases
RC109-216
spellingShingle Urinary tract infections
Antimicrobial resistance
HIV
Uganda
Sub-Saharan Africa
Infectious and parasitic diseases
RC109-216
George Abongomera
Maurice Koller
Joseph Musaazi
Mohammed Lamorde
Marisa Kaelin
Hannington B. Tasimwa
Nadia Eberhard
Jan Hongler
Sabine Haller
Andrew Kambugu
Barbara Castelnuovo
Jan Fehr
Spectrum of antibiotic resistance in UTI caused by Escherichia coli among HIV-infected patients in Uganda: a cross-sectional study
description Abstract Background Antimicrobial drug resistance is one of the top ten threats to global health according to the World Health Organization. Urinary tract infections (UTIs) are among the most common bacterial infections and main reason for antibiotic prescription. The incidence of UTIs appears to be high among people living with HIV. We sought to determine the most common UTI pathogens among HIV infected patients and evaluate their susceptibility towards antibiotics. Methods We performed a cross-sectional study among HIV-infected patients aged ≥ 18 years presenting at an HIV care specialized clinic with symptoms suggestive of a urethritis. Urine cultures were subjected to antibiotic susceptibility testing according to Clinical Laboratory Standards Institute. The data was analyzed using STATA, we performed Pearson’s Chi-square and Fisher’s exact tests to compare differences between proportions. Results Out of the 200 patients, 123 (62%) were female. The median age was 41.9 years (IQR 34.7–49.3). Only 32 (16%) urine cultures showed bacterial growth. Escherichia coli was the most commonly isolated uropathogen (72%), followed by Klebsiella pneumoniae (9%). E. coli was completely resistant to cotrimoxazole and ampicillin; resistance to ciprofloxacin and ceftriaxone was 44% and 35% respectively; 9% to gentamicin; no resistance detected to nitrofurantoin and imipenem. Conclusions Our findings are congruent with the Uganda national clinical guidelines which recommends nitrofurantoin as the first line antibiotic for uncomplicated UTI. Significant ciprofloxacin and ceftriaxone resistance was detected. In the era of emerging antibiotic resistance, understanding the local susceptibilities among sub-populations such as HIV infected patients is crucial. Further investigation is needed to address reasons for the low bacterial growth rate observed in the urine cultures.
format article
author George Abongomera
Maurice Koller
Joseph Musaazi
Mohammed Lamorde
Marisa Kaelin
Hannington B. Tasimwa
Nadia Eberhard
Jan Hongler
Sabine Haller
Andrew Kambugu
Barbara Castelnuovo
Jan Fehr
author_facet George Abongomera
Maurice Koller
Joseph Musaazi
Mohammed Lamorde
Marisa Kaelin
Hannington B. Tasimwa
Nadia Eberhard
Jan Hongler
Sabine Haller
Andrew Kambugu
Barbara Castelnuovo
Jan Fehr
author_sort George Abongomera
title Spectrum of antibiotic resistance in UTI caused by Escherichia coli among HIV-infected patients in Uganda: a cross-sectional study
title_short Spectrum of antibiotic resistance in UTI caused by Escherichia coli among HIV-infected patients in Uganda: a cross-sectional study
title_full Spectrum of antibiotic resistance in UTI caused by Escherichia coli among HIV-infected patients in Uganda: a cross-sectional study
title_fullStr Spectrum of antibiotic resistance in UTI caused by Escherichia coli among HIV-infected patients in Uganda: a cross-sectional study
title_full_unstemmed Spectrum of antibiotic resistance in UTI caused by Escherichia coli among HIV-infected patients in Uganda: a cross-sectional study
title_sort spectrum of antibiotic resistance in uti caused by escherichia coli among hiv-infected patients in uganda: a cross-sectional study
publisher BMC
publishDate 2021
url https://doaj.org/article/f6a2451d3b464a22b21d8e2b08fec13f
work_keys_str_mv AT georgeabongomera spectrumofantibioticresistanceinuticausedbyescherichiacoliamonghivinfectedpatientsinugandaacrosssectionalstudy
AT mauricekoller spectrumofantibioticresistanceinuticausedbyescherichiacoliamonghivinfectedpatientsinugandaacrosssectionalstudy
AT josephmusaazi spectrumofantibioticresistanceinuticausedbyescherichiacoliamonghivinfectedpatientsinugandaacrosssectionalstudy
AT mohammedlamorde spectrumofantibioticresistanceinuticausedbyescherichiacoliamonghivinfectedpatientsinugandaacrosssectionalstudy
AT marisakaelin spectrumofantibioticresistanceinuticausedbyescherichiacoliamonghivinfectedpatientsinugandaacrosssectionalstudy
AT hanningtonbtasimwa spectrumofantibioticresistanceinuticausedbyescherichiacoliamonghivinfectedpatientsinugandaacrosssectionalstudy
AT nadiaeberhard spectrumofantibioticresistanceinuticausedbyescherichiacoliamonghivinfectedpatientsinugandaacrosssectionalstudy
AT janhongler spectrumofantibioticresistanceinuticausedbyescherichiacoliamonghivinfectedpatientsinugandaacrosssectionalstudy
AT sabinehaller spectrumofantibioticresistanceinuticausedbyescherichiacoliamonghivinfectedpatientsinugandaacrosssectionalstudy
AT andrewkambugu spectrumofantibioticresistanceinuticausedbyescherichiacoliamonghivinfectedpatientsinugandaacrosssectionalstudy
AT barbaracastelnuovo spectrumofantibioticresistanceinuticausedbyescherichiacoliamonghivinfectedpatientsinugandaacrosssectionalstudy
AT janfehr spectrumofantibioticresistanceinuticausedbyescherichiacoliamonghivinfectedpatientsinugandaacrosssectionalstudy
_version_ 1718407869222617088